“Aetna and Humana each agreed, in order to extend the ‘End Date’ to waive until 11:59 p.m. on February 15, 2017, its right to terminate the merger agreement due to a failure of the mergers to have been completed on or before December 31, 2016,” a filing with the U.S. Securities and Exchange Commission reads.
This is the second time the insurers extended their agreement deadline, the first being from June 30 to Dec. 31.
The decision arrived as the insurers’ antitrust trial closed in Washington, D.C., Wednesday. DOJ and the insurers’ attorneys will return to court Dec. 30 to make a final, 90-minute argument to overseeing U.S. District Court Judge John Bates.
More articles on payer issues:
Californians lose Medicaid coverage, paperwork backlog blamed
DOJ witness argues Anthem-Cigna deal could impede competition in Connecticut
Cigna names managing director of Europe global health benefits business
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
